| 标题 |
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet HIV 作者:Chloe Orkin; Jean‐Michel Molina; Pedro Cahn; Johannes Lombaard; Khuanchai Supparatpinyo; et al 出版日期:2023-12-20 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)